Correlation Between Merck and Bio Rad

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and Bio Rad at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Bio Rad into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Bio Rad Laboratories, you can compare the effects of market volatilities on Merck and Bio Rad and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Bio Rad. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Bio Rad.

Diversification Opportunities for Merck and Bio Rad

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Merck and Bio is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Bio Rad Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Rad Laboratories and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Bio Rad. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Rad Laboratories has no effect on the direction of Merck i.e., Merck and Bio Rad go up and down completely randomly.

Pair Corralation between Merck and Bio Rad

Considering the 90-day investment horizon Merck Company is expected to generate 0.68 times more return on investment than Bio Rad. However, Merck Company is 1.47 times less risky than Bio Rad. It trades about -0.12 of its potential returns per unit of risk. Bio Rad Laboratories is currently generating about -0.38 per unit of risk. If you would invest  8,996  in Merck Company on January 5, 2025 and sell it today you would lose (849.00) from holding Merck Company or give up 9.44% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Merck Company  vs.  Bio Rad Laboratories

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in May 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Bio Rad Laboratories 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Bio Rad Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in May 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Merck and Bio Rad Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and Bio Rad

The main advantage of trading using opposite Merck and Bio Rad positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Bio Rad can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will offset losses from the drop in Bio Rad's long position.
The idea behind Merck Company and Bio Rad Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes